“…For this purpose, nanocomposites grafted with Phos were subjected to a time delay of 12, 18 and 24 h at 37 1C before bacteria inoculation. 34 Our results showed that in spite of strong binding by intermolecular interactions between these components, the released drug retains its medicinal properties against pathogen microorganism and confirmed that the drug molecule and the nanocomposite are compatible with each other. Nanocomposites grafted with Phos in concentration of 10Â MIC reduced bacterial growth compared to control without cellulose nanofibers (data not shown), but did not result in a complete growth inhibition.…”
Nanocomposite dermal drug delivery systems based on cellulose nanofibers with grafted titania nanoparticles loaded by two antibiotic medicines from different classes, i.e. tetracycline (TC) and phosphomycin (Phos), were successfully produced by a ''green chemistry'' approach in aqueous media. The influence of a different surface binding mechanism between the drug molecule and modified cellulose nanofibers on the release of the drug and, as a result, on antimicrobial properties against common pathogens Gram-positive, Staphylococcus aureus and Gram-negative Escherichia coli was investigated. The disk diffusion method and broth culture tests using varying concentrations of drugs loaded to nanocomposites were carried out to investigate the antibacterial effects. The influence of UV irradiation on the stability of the obtained nanocomposites and their antibacterial properties after irradiation were also investigated, showing enhanced stability especially for the TC loaded materials. These findings suggest that the obtained nanocomposites are promising materials for the development of potentially useful antimicrobial patches.
“…For this purpose, nanocomposites grafted with Phos were subjected to a time delay of 12, 18 and 24 h at 37 1C before bacteria inoculation. 34 Our results showed that in spite of strong binding by intermolecular interactions between these components, the released drug retains its medicinal properties against pathogen microorganism and confirmed that the drug molecule and the nanocomposite are compatible with each other. Nanocomposites grafted with Phos in concentration of 10Â MIC reduced bacterial growth compared to control without cellulose nanofibers (data not shown), but did not result in a complete growth inhibition.…”
Nanocomposite dermal drug delivery systems based on cellulose nanofibers with grafted titania nanoparticles loaded by two antibiotic medicines from different classes, i.e. tetracycline (TC) and phosphomycin (Phos), were successfully produced by a ''green chemistry'' approach in aqueous media. The influence of a different surface binding mechanism between the drug molecule and modified cellulose nanofibers on the release of the drug and, as a result, on antimicrobial properties against common pathogens Gram-positive, Staphylococcus aureus and Gram-negative Escherichia coli was investigated. The disk diffusion method and broth culture tests using varying concentrations of drugs loaded to nanocomposites were carried out to investigate the antibacterial effects. The influence of UV irradiation on the stability of the obtained nanocomposites and their antibacterial properties after irradiation were also investigated, showing enhanced stability especially for the TC loaded materials. These findings suggest that the obtained nanocomposites are promising materials for the development of potentially useful antimicrobial patches.
“…Consequently, drug molecule and nanocomposite are compatible with each other. It is important to mention that strong chemical interaction between these components may lead to complete loss of medical properties of drugs 45 . At the same time, there is possibility of intermolecular interactions since the drug molecule contains various functional groups.…”
Section: Preparation and Characterization Of Nanocomposite Tio 2 mentioning
Nanocomposites with potential for dermal drug delivery have been developed using nanotitania chemically grafted onto nanocellulose as an active ingredient for enhanced uptake and controlled release of model drug loads.
“…The formation of similar inclusion complexes was confirmed on the basis of the IR spectra of SD carbendazim (synonym:medamine), ABZ, fenbendazole (FBZ), and triclabendazole (TCB) with PVP and Arabinogalactan (AG) [35]. Under similar conditions, the medamine substance was subjected to joint mechanical treatment with Microcrystalline cellulose (MCC) [41,42], with plant proanthocyanidines [43], and the corresponding SD were obtained, which had increased solubility in water, better permeability through model semipermeable membranes, and, hence, increased bioavailability.…”
Section: Solid Dispersions Of Anthelmintics For Animal Healthmentioning
Because of the rapid development of nanotechnologies, materials, in particular, solid dispersions (SDs), which are actively introduced into the life of modern man, have been obtained. Special progress in this area is observed in industry and medicine. The use of SDs in agriculture is lagging far behind, despite the growing number of scientific papers on this topic. At the same time, the prospects for the introduction of SDs in the agro-industrial complex are obvious. The review presents the results of research on the development of innovative preparations based on SD to protect plants from diseases and pests of cultivated plants, as well as parasiticides to protect animal health based on modern achievements of nanotechnology. One of these technologies is the methods of mechanochemistry, which improve the properties of poorly soluble biologically active substances by their joint mechanical treatment with water-soluble polymers and auxiliary substances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.